semaglutide kidney side effects Safety and Efficacy of in Patients With Chronic Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta‐Analysis Is it safe to start

Front Aging Neurosci 15:1281338 [DOI] [PMC free article] [PubMed] [Google Scholar] Barone E et al (2021) The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease

Tirzepatide shows a slightly higher reported incidence of nausea during early treatment phases compared to semaglutide in clinical trials, though the difference is modest

Has it been out of the fridge recently

If the baseline risk of gallbladder disease is roughly 1% per year in the general population, tirzepatide might increase that to approximately 1.5% to 2%